Clinical Trial Update: Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)

View source ↗

Summary

Clinical trial update on intranasal AAV9-PHP.eB gene therapy being studied for cerebral palsy and hypoxic ischemic encephalopathy, currently enrolling by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• Intranasal AAV9-PHP.eB gene therapy (AAV9-PHP.eB intranasal gene therapy)

Snippet

Sponsor: Healing Hope International | Conditions: Hypoxic Brain Damage, Hypoxic Ischaemic Encephalopathy (HIE) | Status: ENROLLING_BY_INVITATION